The Latest Breaking News from Vaccine

The Australian regulatory authority has conditionally approved Novavax Inc's (NASDAQ:NVAX) Nuvaxovid (NVX-CoV2373) COVID-19 vaccine as a booster in individuals aged 18 and over. The provisional registration was based on data from Novavax's Phase 2 trial conducted in Australia, wherein a single booster dose of Nuvaxovid was administered to healthy adult participants approximately six months after…

When we’re exposed to a pathogen such as a virus, our immune system identifies it as a foreign invader and mounts an attack. This ultimately results in the formation of antibodies which can neutralise the invading pathogen next time we encounter it.

Anti-vaccine sentiment could see some Dickensian illnesses 'bounce back', experts have warned

A review by federal health officials says that Pfizer's COVID-19 vaccine appears safe and effective for children under 5, the only group not currently eligible for vaccination

China's urban populations have been enduring some of the most intense infection-prevention measures of the Covid-19 pandemic. For 60 straight days, Shanghai's 27 million residents were forced into a strict lockdown -- and they were not alone. During the peak of the Omicron BA.2 wave in the past two months,…

Bunny owners and vets weigh in with their advice and concerns about the lethal rabbit disease RHDV2 and the recent vaccine.

Novavax now in financial trouble after missing peak vaccinations

FORT LAUDERDALE, Fla.— As Gov. Ron DeSantis fights COVID-19 vaccination passports and mandates — most recently by threatening the Special Olympics with a $27.5 million fine — there’s one mandate he can’t stop.

Researchers trying to protect Tasmanian devils are given a "huge boost" in the battle against a deadly disease that has wreaked havoc in the wild, thanks to an unlikely source — the COVID-19 vaccine.